Casdin 资本 对 BLFS 的持仓历史
BIOLIFE SOLUTIONS INC · 医疗保健
Casdin 资本 在 Q3 2026 的 13F 申报中披露持有 BLFS(BIOLIFE SOLUTIONS INC)4,500,000 股,市值约 US$174.8M,约占其申报组合的 7.64%,在其申报持仓中市值排名第 4 位。 Casdin 资本 最近 34 个申报季度中有 34 个季度披露了 BLFS 持仓,最早可追溯至 Q2 2018。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Casdin 资本 对 BLFS 的持仓演变
Casdin 资本 于 Q2 2018 首次披露 BLFS 持仓:1,000,000 股(约 US$11.4M)。 该持仓在 Q3 2019 达到峰值 2,428,571 股,市值约 US$40.37B。 在 34 次申报中,Casdin 资本 9 次增持、5 次减持、19 次保持不变。 最近一期申报(Q3 2026)显示持股 4,500,000 股、市值约 US$174.8M,环比减持 -155,000 股。。 持仓曾出现大幅变动:Q3 2018 增持约 143%、Q2 2020 增持约 96%、Q4 2020 增持约 27%。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2018 | 1.00M | $11.41M | 新进 |
| Q3 2018 | 2.43M | $42.50M | 增持 |
| Q4 2018 | 2.43M | $29.22M | 持有 |
| Q1 2019 | 2.43M | $43.45M | 持有 |
| Q2 2019 | 2.43M | $39.41B | 持有 |
| Q3 2019 | 2.43M | $40.37B | 持有 |
| Q4 2019 | 2.47M | $39.94M | 增持 |
| Q1 2020 | 2.47M | $23.45M | 持有 |
| Q2 2020 | 4.85M | $79.29M | 增持 |
| Q3 2020 | 5.84M | $169.01M | 增持 |
| Q4 2020 | 7.44M | $296.79M | 增持 |
| Q1 2021 | 7.44M | $267.84M | 持有 |
| Q2 2021 | 7.44M | $331.16M | 持有 |
| Q3 2021 | 7.57M | $320.20M | 增持 |
| Q4 2021 | 7.57M | $282.00M | 持有 |
| Q1 2022 | 7.57M | $171.98M | 持有 |
| Q2 2022 | 7.57M | $104.49M | 持有 |
| Q3 2022 | 7.57M | $172.13M | 持有 |
| Q4 2022 | 7.57M | $137.74M | 持有 |
| Q1 2023 | 7.57M | $164.68M | 持有 |
| Q2 2023 | 7.72M | $170.65M | 增持 |
| Q3 2023 | 7.78M | $107.44M | 增持 |
| Q4 2023 | 8.71M | $141.49M | 增持 |
| Q1 2024 | 8.71M | $161.52M | 持有 |
| Q2 2024 | 8.71M | $186.59M | 持有 |
| Q3 2024 | 8.71M | $218.03M | 持有 |
| Q4 2024 | 8.71M | $226.04M | 持有 |
| Q1 2025 | 8.71M | $198.87M | 持有 |
| Q2 2025 | 7.71M | $166.01M | 减持 |
| Q3 2025 | 6.71M | $171.10M | 减持 |
| Q4 2025 | 5.96M | $144.04M | 减持 |
| Q1 2026 | 5.96M | $113.66M | 持有 |
| Q2 2026 | 4.66M | $131.46M | 减持 |
| Q3 2026 | 4.50M | $174.82M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BLFS 与 13F 数据
BLFS(BIOLIFE SOLUTIONS INC)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 BLFS,申报仓位最大的包括:First Trust Capital Management L.P. (US$55.4M), AQR Arbitrage LLC (US$43.8M), Magnetar Financial LLC (US$42.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BLFS 的基金
- First Trust Capital Management L.P. 1.43M 股 · $55.36M · Q3 2026
- AQR Arbitrage LLC 1.13M 股 · $43.84M · Q3 2026
- Magnetar Financial LLC 1.09M 股 · $42.52M · Q3 2026
- Polar Asset Management Partners Inc. 816.68K 股 · $31.73M · Q3 2026
- WATER ISLAND CAPITAL LLC 716.00K 股 · $27.82M · Q3 2026
- GAGNON SECURITIES LLC 532.10K 股 · $20.67M · Q3 2026
- ALPINE ASSOCIATES MANAGEMENT INC. 393.60K 股 · $15.29M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 348.40K 股 · $13.54M · Q3 2026
更多关于 Casdin 资本
常见问题
How long has Casdin 资本 held BLFS?
Casdin 资本 has disclosed BLFS holdings in 34 of the last 34 reported quarters, going back to Q2 2018.
What is Casdin 资本's current position in BLFS?
As of Q3 2026, Casdin 资本 holds 4.50M shares of BLFS (BIOLIFE SOLUTIONS INC), valued at $174.82M, representing 7.64% of its reported portfolio and ranking #4.
Has Casdin 资本 been buying or selling BLFS?
In the latest 13F filing (Q3 2026), Casdin 资本 reduced its position in BLFS. The position peaked in Q3 2019 at 2.43M shares.
Which other funds hold BLFS?
Other major institutional holders of BLFS include First Trust Capital Management L.P., AQR Arbitrage LLC, Magnetar Financial LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.